BiotechTube
Home/ADMA Biologics/Michele L. Willkommen
ML

Michele L. Willkommen

Chief Operations Officer

ADMA Biologics

Therapeutic Areas

Primary ImmunodeficiencyInfectious DiseasesSecondary Immunodeficiency

ADMA Biologics Pipeline

DrugIndicationPhase
ASCENIVPrimary Immunodeficiency Diseases (PIDD)Marketed
BIVIGAMPrimary Humoral ImmunodeficiencyMarketed
Nabi-HBHepatitis B Post-Exposure ProphylaxisMarketed
IVIG Portfolio ExpansionSecondary ImmunodeficiencyLifecycle Management

Leadership Team at ADMA Biologics

AS
Adam S. Grossman
President, Chief Executive Officer and Director
BM
Bryan M. Reasons
Chief Financial Officer
SA
Steven A. Elms
Chairman of the Board
JG
James G. Mond
Chief Medical Officer
View full ADMA Biologics profile